Neil Stahl - Dec 9, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research and Development
Signature
/s/ Neil E. Stahl
Stock symbol
REGN
Transactions as of
Dec 9, 2024
Transactions value $
-$366,742
Form type
4
Date filed
12/10/2024, 04:03 PM
Previous filing
Aug 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Tax liability -$367K -466 -0.94% $787.00 49.1K Dec 9, 2024 Direct
holding REGN Common Stock 5.85K Dec 9, 2024 By 401(k) Plan
holding REGN Common Stock 4.61K Dec 9, 2024 by Spouse as Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.